DIAGNOS Statistics

Total Valuation

DIAGNOS has a market cap or net worth of CAD 20.37 million. The enterprise value is 20.21 million.

Market Cap	20.37M
Enterprise Value	20.21M

Important Dates

The last earnings date was Friday, June 6, 2025.

Earnings Date	Jun 6, 2025
Ex-Dividend Date	n/a

Share Statistics

DIAGNOS has 101.86 million shares outstanding. The number of shares has increased by 21.23% in one year.

Current Share Class	101.86M
Shares Outstanding	101.86M
Shares Change (YoY)	+21.23%
Shares Change (QoQ)	+5.60%
Owned by Insiders (%)	4.91%
Owned by Institutions (%)	n/a
Float	96.86M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	196.27
PB Ratio	87.39
P/TBV Ratio	87.39
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.71
EV / Sales	194.70
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.53

Financial Position

The company has a current ratio of 1.11, with a Debt / Equity ratio of 13.18.

Current Ratio	1.11
Quick Ratio	1.08
Debt / Equity	13.18
Debt / EBITDA	n/a
Debt / FCF	-0.84
Interest Coverage	-6.44

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-111.17%
Return on Invested Capital (ROIC)	-139.02%
Return on Capital Employed (ROCE)	-736.62%
Revenue Per Employee	4,718
Profits Per Employee	-194,839
Employee Count	22
Asset Turnover	0.05
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -37.50% in the last 52 weeks. The beta is -0.65, so DIAGNOS's price volatility has been lower than the market average.

Beta (5Y)	-0.65
52-Week Price Change	-37.50%
50-Day Moving Average	0.23
200-Day Moving Average	0.30
Relative Strength Index (RSI)	39.09
Average Volume (20 Days)	123,026

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, DIAGNOS had revenue of CAD 103,797 and -4.29 million in losses. Loss per share was -0.05.

Revenue	103,797
Gross Profit	-943,561
Operating Income	-3.82M
Pretax Income	-4.29M
Net Income	-4.29M
EBITDA	-3.81M
EBIT	-3.82M
Loss Per Share	-0.05

Full Income Statement

Balance Sheet

The company has 3.24 million in cash and 3.07 million in debt, giving a net cash position of 163,705 or 0.00 per share.

Cash & Cash Equivalents	3.24M
Total Debt	3.07M
Net Cash	163,705
Net Cash Per Share	0.00
Equity (Book Value)	233,110
Book Value Per Share	0.00
Working Capital	348,957

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -3.64 million and capital expenditures -13,723, giving a free cash flow of -3.65 million.

Operating Cash Flow	-3.64M
Capital Expenditures	-13,723
Free Cash Flow	-3.65M
FCF Per Share	-0.04

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-3,684.24%
Pretax Margin	-4,129.65%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

DIAGNOS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-21.23%
Shareholder Yield	n/a
Earnings Yield	-21.04%
FCF Yield	-17.92%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 24, 2019. It was a reverse split with a ratio of 0.1.

Last Split Date	Apr 24, 2019
Split Type	Reverse
Split Ratio	0.1

Scores

DIAGNOS has an Altman Z-Score of -19.48 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-19.48
Piotroski F-Score	3